高剂量伐昔洛韦预防肾移植后巨细胞病毒感染的肾脏安全性 - Suppr | 超能文献

The renal safety of high doses of valacyclovir for prevention of cytomegalovirus infection after renal transplantation.

作者信息

Le Meur Y, Mons S, Moesch C, Leroux-Robert C

出版信息

Nephrol Dial Transplant. 2000 Mar;15(3):442. doi: 10.1093/ndt/15.3.442.

DOI:10.1093/ndt/15.3.442

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

The renal safety of high doses of valacyclovir for prevention of cytomegalovirus infection after renal transplantation.高剂量伐昔洛韦预防肾移植后巨细胞病毒感染的肾脏安全性

Nephrol Dial Transplant. 2000 Mar;15(3):442. doi: 10.1093/ndt/15.3.442.

2

Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group.伐昔洛韦预防肾移植后巨细胞病毒病。国际伐昔洛韦预防巨细胞病毒移植研究组。

N Engl J Med. 1999 May 13;340(19):1462-70. doi: 10.1056/NEJM199905133401903.

3

Prophylaxis of human cytomegalovirus infection in renal transplant patients with valacyclovir and ganciclovir.伐昔洛韦和更昔洛韦对肾移植患者人巨细胞病毒感染的预防作用

Acta Virol. 2013;57(3):375-7.

4

The efficacy and cost-effectiveness of valacyclovir in cytomegalovirus prevention in solid organ transplantation.伐昔洛韦在实体器官移植中预防巨细胞病毒感染的疗效及成本效益

Expert Rev Pharmacoecon Outcomes Res. 2014 Dec;14(6):771-9. doi: 10.1586/14737167.2014.965157. Epub 2014 Sep 25.

5

Valacyclovir-associated neurotoxicity in peritoneal dialysis patients.腹膜透析患者中与伐昔洛韦相关的神经毒性

Am J Ther. 2014 Nov-Dec;21(6):e215-7. doi: 10.1097/MJT.0b013e318289bae9.

6

A randomized prospective controlled trial of oral ganciclovir versus oral valacyclovir for prophylaxis of cytomegalovirus disease after renal transplantation.口服更昔洛韦与口服伐昔洛韦预防肾移植后巨细胞病毒病的随机前瞻性对照试验。

Transpl Int. 2002 Dec;15(12):615-22. doi: 10.1007/s00147-002-0475-0. Epub 2002 Nov 5.

7

Prophylaxis of cytomegalovirus infection in renal transplantation: new data for an old problem.肾移植中巨细胞病毒感染的预防：老问题的新数据

Nephrol Dial Transplant. 1999 Oct;14(10):2304-8. doi: 10.1093/ndt/14.10.2304.

8

Randomized trial of valganciclovir versus valacyclovir prophylaxis for prevention of cytomegalovirus in renal transplantation.缬更昔洛韦与伐昔洛韦预防肾移植受者巨细胞病毒感染的随机试验

Clin J Am Soc Nephrol. 2015 Feb 6;10(2):294-304. doi: 10.2215/CJN.07020714. Epub 2014 Nov 25.

9

Prophylaxis of cytomegalovirus infection in renal transplantation.肾移植中巨细胞病毒感染的预防

Nephrol Dial Transplant. 2001 Nov;16(11):2276-9. doi: 10.1093/ndt/16.11.2276.

10

Valacyclovir for the prevention of cytomegalovirus infection after kidney transplantation is associated with macrocytosis.伐昔洛韦用于预防肾移植后巨细胞病毒感染与大红细胞症相关。

Am J Transplant. 2003 Jan;3(1):94-5. doi: 10.1034/j.1600-6143.2003.30118.x.

引用本文的文献

1

Real-world safety of maribavir: a retrospective study based on signal detection in the FDA adverse event reporting system.马瑞巴韦的真实世界安全性：一项基于美国食品药品监督管理局不良事件报告系统信号检测的回顾性研究。

Int J Clin Pharm. 2025 Jun;47(3):767-774. doi: 10.1007/s11096-025-01869-4. Epub 2025 Jan 17.

2

Acute retinal necrosis: A mini review.急性视网膜坏死：一篇综述

Front Ophthalmol (Lausanne). 2022 Aug 22;2:916113. doi: 10.3389/fopht.2022.916113. eCollection 2022.

3

Evaluation of pharmacokinetic interactions after oral administration of mycophenolate mofetil and valaciclovir or aciclovir to healthy subjects.对健康受试者口服霉酚酸酯与伐昔洛韦或阿昔洛韦后药代动力学相互作用的评估。

Clin Pharmacokinet. 2004;43(10):685-92. doi: 10.2165/00003088-200443100-00004.